Volume 29, Issue 3 (Summer 2021)                   Avicenna J Nurs Midwifery Care 2021, 29(3): 256-263 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sabetsarvestani P, Rahnavard S, Hatami M, Bijani M, Nikrooz L. Investigating the Demographic Characteristics, Clinical Signs, Radiological and Laboratory Findings in Pregnant Women with COVID-19: A Cross-Sectional Study in Southern Iran. Avicenna J Nurs Midwifery Care 2021; 29 (3) :256-263
URL: http://nmj.umsha.ac.ir/article-1-2233-en.html
1- Instructor, Department of Medical-Surgical Nursing, Fasa University of Medical Sciences Fasa, Iran
2- Student Research Committee, Fasa University of Medical Sciences, Fasa, Iran
3- Associate Professor, Department of Medical-Surgical Nursing, Fasa University of Medical Sciences Fasa, Iran , bizhani _mostafa @yahoo.com
4- Associate Professor, Department of Medical-Surgical Nursing, Fasa University of Medical Sciences Fasa, Iran
Abstract:   (3091 Views)

Background and Objective: Pregnant women are one of the vulnerable groups against COVID-19. Understanding the affected population characteristics helps to identify risk factors and set more effective treatment goals; in this regard, the present study tries to review demographic characteristics, clinical signs, radiological and laboratory findings in pregnant women with COVID-19 in southern Iran.
Material and Methods: This descriptive cross-sectional study was conducted on 30 pregnant women with COVID-19 who were selected from teaching hospitals in Fasa, Jahrom, and Shiraz in Fars province. Sampling was done through the convenience method from March to July 2020. A researcher-made checklist was applied to gather the required data which were analyzed using SPSS 22 software and descriptive statistics.
Results: The mean age of patients was 28.30±9.96 years. Of patients, 60% were in the first trimester of pregnancy. The average length of stay in a hospital was 8.47±4.37 days. Fever (46/66 %) was the most common clinical finding, increased C-reactive protein (CRP) levels (50%) was the most common laboratory finding, and Ground Glossy Opacity (GGO) (56/66 %) was the most common radiological finding in both lungs. Of pregnant women, 80% with COVID-19 had an underlying disease. The most common underlying diseases were 36.66% for asthma and 20% for diabetes. Of normal deliveries, 53.33% and 3.33% of neonatal and maternal deaths were reported.
Conclusion: The most common time for COVID-19 in pregnant women was reported in the first trimester of pregnancy with clinical signs of fever and a history of asthma and diabetes. Therefore, the findings of this study highlight the importance of paying attention to pregnant women as one of the most at-risk groups in the COVID-19 pandemic. Health policy makers can use the findings of this study and the reported outcomes to develop appropriate health protocols for health care of pregnant women in the COVID-19 pandemic.

Persian Full-Text [PDF 440 kb]   (822 Downloads) |   |   Extended Abstract (HTML)  (568 Views)  

✅ According to the results, prolonged stay in an intensive care unit, the elderly, and polypharmacy are the main important factors associated with the occurrence of drug-drug interactions. These results indicate the importance of paying more attention to the monitoring and control of prescribed drugs in these patients.


Type of Study: Original Research | Subject: Midwifery
Received: 2020/09/9 | Accepted: 2020/11/23 | Published: 2021/09/21

References
1. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5]
2. Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-9. [DOI:10.1001/jama.2020.1585] [PMID] [PMCID]
3. World Health Organization. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. World Health Organ;2020. Available at: https://apps.who.int [DOI:10.15557/PiMR.2020.0003]
4. Greenberg N, Docherty M, Gnanapragasam S, Wessely S. Managing mental health challenges faced by healthcare workers during COVID-19 pandemic. BMJ. 2020;368:1-4 [DOI:10.1136/bmj.m1211] [PMID]
5. Wang J, Zhou M, Liu, F. Reasons for health care workers becoming infected with novel coronavirus disease 2019 (COVID-19) in China. J Hosp Infect. 2020;105:100-1. [DOI:10.1016/j.jhin.2020.03.002] [PMID] [PMCID]
6. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382(8):727-33 [DOI:10.1056/NEJMoa2001017] [PMID] [PMCID]
7. Baud D, Qi X, Nielsen-Saines K, Musso D, Pomar L, Favre G. Real estimates of mortality following COVID-19 infection. Lancet Infect Dis. 2020;20(7):773. [DOI:10.1016/S1473-3099(20)30195-X]
8. Chen H, Guo J, Wang C, Luo F, Yu X, Zhang W, et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. The lancet. 2020 Mar 7;395(10226):809-15. [DOI:10.1016/S0140-6736(20)30360-3]
9. Farnoosh G, Alishiri G, Zijoud SH, Dorostkar R, Farahani AJ. Understanding the Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease (COVID-19) based on available evidence - a narrative review. J Mil Med. 2020; 22 (1):1-11
10. Park MH, Kim HR, Choi DH, Sung JH, Kim JH. Emergency cesarean section in an epidemic of the middle east respiratory syndrome: a case report. Korean J Anesthesiol. 2016;69(3):287. [DOI:10.4097/kjae.2016.69.3.287] [PMID] [PMCID]
11. Elshafeey F, Magdi R, Hindi N, Elshebiny M, Farrag N, Mahdy S, et al. A systematic scoping review of COVID‐19 during pregnancy and childbirth. Int J Gynecol Obstet. 2020. [DOI:10.1002/ijgo.13182] [PMID]
12. Poon LC, Yang H, Lee JC, Copel JA, Leung TY, Zhang Y, et al. ISUOG Interim Guidance on 2019 novel coronavirus infection during pregnancy and puerperium: information for healthcare professionals. Ultrasound Obstet Gynecol. 2020; 55(5):700-8. [DOI:10.1002/uog.22013] [PMID] [PMCID]
13. Qiao J. What are the risks of COVID-19 infection in pregnant women? Lancet. 2020; 395(10226):760-2. [DOI:10.1016/S0140-6736(20)30365-2]
14. Yang H, Wang C, Poon LC. Novel coronavirus infection and pregnancy. Ultrasound Obstet Gynecol. 2020; 55(4):435-7 [DOI:10.1002/uog.22006] [PMID] [PMCID]
15. Liu D, Li L, Wu X, Zheng D, Wang J, Yang L, et al. Pregnancy and Perinatal Outcomes of Women With Coronavirus Disease (COVID-19) Pneumonia: A Preliminary Analysis. Am J Roentgenol. 2020:1-6. [DOI:10.2139/ssrn.3548758]
16. Li Q, Guan X, Wu P, Wang X, Zhou L, Tong Y, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020;382(13):1199-207 [DOI:10.1056/NEJMoa2001316] [PMID] [PMCID]
17. Sattari M, Bashirian S, Masoumi SZ, Shayan A, Jenabi E, Ghelichkhani S, et al. Evaluating Clinical Course and risk factors of Infection and demographic characteristics of pregnant women with COVID-19 in Hamadan Province, West of Iran. J Res Health Sci. 2020; 20(3): 1-5 [DOI:10.34172/jrhs.2020.22] [PMID] [PMCID]
18. Ellington S, Strid P, Tong VT, Woodworth K, Galang RR, Zambrano LD, et al. Characteristics of women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status - United States, January 22-June 7, 2020. Morb Mortal Wkly Rep. 2020;69(25):770-5 [DOI:10.15585/mmwr.mm6925a1] [PMID] [PMCID]
19. Nikpour M, Behmanesh F, Darzipoor M, Haddad Zavareh MS. Pregnancy outcomes and clinical manifestations of Covid-19 in Pregnant Women: a narrative review. J Mil Med. 2020;22(2):177-83
20. Schwartz DA. An Analysis of 38 Pregnant Women with COVID-19, Their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med. 2020;144(7):799-805 [DOI:10.5858/arpa.2020-0901-SA] [PMID]
21. Zeng L, Xia S, Yuan W, Yan K, Xiao F, Shao J, et al. Neonatal early-onset infection with SARSCoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 2020;174(7):722-5 [DOI:10.1001/jamapediatrics.2020.0878] [PMID] [PMCID]
22. Yu N, Li W, Kang Q, Xiong Z, Wang S, Lin X, et al. Clinical features and obstetric and outcomes of pregnant patients with COVID-19 in Wuhan, China: a retrospective, single-centre,descriptive study. Lancet Infect Dis. 2020;20:559-64 [DOI:10.1016/S1473-3099(20)30176-6]
23. Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, Xia S, Zhou W. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020;9:51-60. [DOI:10.21037/tp.2020.02.06] [PMID] [PMCID]
24. Monteleone PA, Nakano M, Lazar V, Gomes AP, de Martin H, Bonetti TC. A review of initial data on pregnancy during the COVID-19 outbreak: implications for assisted reproductive treatments. JBRA Assist Reprod. 2020; 24(2): 219-25. [DOI:10.5935/1518-0557.20200030] [PMID] [PMCID]

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Avicenna Journal of Nursing and Midwifery Care

Designed & Developed by : Yektaweb